- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Phaxiam Therapeutics SA (0QSS)
1.88
0.00(0.00%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.88
1.88
52 wk Range
1.65
4.83
0QSS Scorecard
Full Analysis
Analysts anticipate sales decline in the current year
Assess today's live Phaxiam Therapeutics SA (PHXM) share price, performance and insights using our live Paris: PHXM stock exchange data.
Analyse the historical data and Phaxiam Therapeutics SA share price performance charts on this page. Our technical summary section provides analysis on Phaxiam Therapeutics share price buy/sell indicators using real-time data (or discuss the Phaxiam Therapeutics (PHXM) stock price today with other investors in the Phaxiam Therapeutics EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA PHXM share price (ISIN: FR001400K4B1) to enhance your trading decisions with our free investment tools and resources.
What Is the Phaxiam Therapeutics SA Share Price Today?
The Phaxiam Therapeutics share price today is 1.88.
What Is the Stock Symbol for Phaxiam Therapeutics SA
The stock symbol (or 'ticker') for Phaxiam Therapeutics SA is "PHXM."
What Stock Exchange Does Phaxiam Therapeutics SA Trade On?
Phaxiam Therapeutics SA is listed and trades on the Paris stock exchange.
Is Phaxiam Therapeutics SA a Good Stock to Buy?
Determining whether Phaxiam Therapeutics SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Phaxiam Therapeutics SA share price performance charts on this page. Our technical summary section provides analysis on Phaxiam Therapeutics share price buy/sell indicators using real-time data (or discuss the Phaxiam Therapeutics (PHXM) stock price today with other investors in the Phaxiam Therapeutics EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA PHXM share price (ISIN: FR001400K4B1) to enhance your trading decisions with our free investment tools and resources.
What Is the Phaxiam Therapeutics SA Share Price Today?
The Phaxiam Therapeutics share price today is 1.88.
What Is the Stock Symbol for Phaxiam Therapeutics SA
The stock symbol (or 'ticker') for Phaxiam Therapeutics SA is "PHXM."
What Stock Exchange Does Phaxiam Therapeutics SA Trade On?
Phaxiam Therapeutics SA is listed and trades on the Paris stock exchange.
Is Phaxiam Therapeutics SA a Good Stock to Buy?
Determining whether Phaxiam Therapeutics SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.881.88
52 wk Range
1.654.83
Unlock0QSS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
5.10
Upside
+183.02%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Phaxiam Therapeutics SA Company Profile
PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing a portfolio of phages targeting resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections, including staphylococcus aureus, escherichia coli, and pseudomonas aeruginosa. The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. PHAXIAM Therapeutics S.A. was incorporated in 2004 and is headquartered in Lyon, France.
Compare 0QSS to Peers and Sector
Metrics to compare | 0QSS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0QSSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −3.7x | −0.6x | |
PEG Ratio | - | −0.02 | 0.00 | |
Price/Book | 0.7x | 0.0x | 2.6x | |
Price / LTM Sales | 8.4x | 5.0x | 3.2x | |
Upside (Analyst Target) | - | 162.0% | 48.5% | |
Fair Value Upside | Unlock | 3.3% | 7.8% | Unlock |
People Also Watch
FAQ
What Is the Phaxiam Therapeutics (0QSS) Stock Price Today?
The Phaxiam Therapeutics stock price today is 1.88
What Stock Exchange Does Phaxiam Therapeutics Trade On?
Phaxiam Therapeutics is listed and trades on the London stock exchange.
What Is the Stock Symbol for Phaxiam Therapeutics?
The stock symbol for Phaxiam Therapeutics is "0QSS."
What Is the Phaxiam Therapeutics Market Cap?
As of today, Phaxiam Therapeutics market cap is 18.04M.
What is Phaxiam Therapeutics Earnings Per Share?
The Phaxiam Therapeutics EPS is -5.00.
What Is the Next Phaxiam Therapeutics Earnings Date?
Phaxiam Therapeutics will release its next earnings report on 13 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.